Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 23

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 23
---
 those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described herein under “Risk Factors”. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this proxy

TABLE OF CONTENTS

statement, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements as predictions of future results. Our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. You should also carefully consider the risk factors described in “**

#### Risk Factors
” beginning on page 26of this proxy statement/prospectus.

TABLE OF CONTENTS

TABLE OF CONTENTS

| ​                                                                                                  | ​ | ​ | Page |   |      |   | ​ |
| FREQUENTLY USED TERMS                                                                              | ​ | ​ | ​    | ​ |  iii | ​ | ​ |
| QUESTIONS AND ANSWERS ABOUT THE PROPOSALS FOR STOCKHOLDERS                                         | ​ | ​ | ​    | ​ | viii | ​ | ​ |
| SUMMARY OF THE PROXY STATEMENT/PROSPECTUS                                                          | ​ | ​ | ​    | ​ |    1 | ​ | ​ |
| SUMMARY HISTORICAL FINANCIAL INFORMATION OF IRIS                                                   | ​ | ​ | ​    | ​ |   23 | ​ | ​ |
| SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION                               | ​ | ​ | ​    | ​ |   25 | ​ | ​ |
| RISK FACTORS                                                                                       | ​ | ​ | ​    | ​ |   26 | ​ | ​ |
| UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL